Vaccines

Prophylactic and therapeutic vaccines including mRNA platforms, viral vectors, and nanoparticle-based approaches.

Companies

Pipeline Drugs

105

Key People

Vaccines Pipeline (105 drugs)

Commercial: 45Approved: 30Phase 3: 6Phase 2/3: 4Pre-clinical: 4Various Phases: 3Clinical: 2Phase 1: 2Phase 2: 2Phase 1/2: 2Various: 2Phase 1-3: 1Multiple Phases: 1Phase 2b/3: 1

Drug	Company	Indication	Phase	Status
Keytruda (pembrolizumab)	Merck	Multiple Cancer Types	Commercial	Active
Gardasil/Gardasil 9	Merck	HPV Prevention	Commercial	Active
Lynparza (olaparib)	Merck	Various Cancers	Commercial	Active
Lenvima (lenvatinib)	Merck	Thyroid/Liver/Kidney Cancer	Commercial	Active
CORTONE (cortisone)	Merck	Rheumatoid Arthritis	Commercial	Active
Streptomycin	Merck	Tuberculosis	Commercial	Historical
Sulfaquinoxaline (S.Q.)	Merck	Animal Health - Coccidiosis	Commercial	Active
Comirnaty (COVID-19 Vaccine)	Pfizer	SARS-CoV-2 Prevention	Approved	Commercial
Paxlovid	Pfizer	COVID-19 Treatment	Approved	Commercial
Elrexfio	Pfizer	Multiple Myeloma	Approved	Commercial
Abrysvo	Pfizer	RSV Prevention	Approved	Commercial
Obesity Pipeline Programs	Pfizer	Weight Management	Phase 2/3	Active
Oncology Portfolio	Pfizer	Various Cancers	Phase 1-3	Multiple Active Programs
Type 2 Diabetes Therapies	Pfizer	Diabetes Management	Phase 2/3	Active
Cardiovascular Treatments	Pfizer	Heart Disease	Phase 2/3	Active
Inflammation & Immunology Programs	Pfizer	Autoimmune Diseases	Phase 2/3	Active
Venglustat	Sanofi	Type 3 Gaucher disease	Phase 3	Breakthrough Therapy designation
Rilzabrutinib	Sanofi	IgG4-related disease	Clinical	Orphan drug designation
Dupixent	Sanofi	Atopic dermatitis	Commercial	Marketed
Toujeo	Sanofi	Diabetes	Commercial	Marketed
Lantus	Sanofi	Diabetes	Commercial	Marketed
Blenrep (belantamab mafodotin)	GSK plc	Multiple Myeloma	Approved	Active
Jemperli (dostarlimab)	GSK plc	Endometrial Cancer	Approved	Active
Nucala (mepolizumab)	GSK plc	Severe Asthma	Approved	Active
Trelegy Ellipta	GSK plc	COPD, Asthma	Approved	Commercial
Shingrix	GSK plc	Herpes Zoster	Approved	Commercial
Arexvy	GSK plc	RSV	Approved	Commercial
GSK3844766	GSK plc	HIV	Phase 1	Active
GSK3640254	GSK plc	Pulmonary Arterial Hypertension	Phase 2	Active
Cabotegravir LA	GSK plc	HIV PrEP	Approved	Commercial
GSK4362676	GSK plc	Solid Tumors	Phase 1	Active
CSL112	CSL	Acute Coronary Syndrome	Phase 3	Active
CSL312	CSL	Hereditary Angioedema	Phase 3	Active
Eteplirsen	CSL	Duchenne Muscular Dystrophy	Commercial	Marketed
Hemgenix (CSL222)	CSL	Hemophilia B	Commercial	FDA Approved
CSL200	CSL	Wilson Disease	Phase 1/2	Active
Albumin Products	CSL	Multiple Critical Care Indications	Commercial	Marketed
Immunoglobulin Therapies	CSL	Primary Immunodeficiencies	Commercial	Marketed
Factor VIII Products	CSL	Hemophilia A	Commercial	Marketed
Credelio (lotilaner)	Elanco	Flea and tick control in dogs and cats	Commercial	Active
Trifexis	Elanco	Flea, heartworm, and intestinal parasites in dogs	Commercial	Active
Advantage/Advantix	Elanco	Flea and tick control	Commercial	Active
Seresto	Elanco	Long-acting flea and tick collar	Commercial	Active
Rumensin	Elanco	Feed efficiency in cattle	Commercial	Active
Optaflexx	Elanco	Growth promotion in cattle	Commercial	Active
Artesun® (Artesunate for Injection)	Fosun Pharma	Severe Malaria	Approved	Commercial - WHO First-line Treatment
Oncology Pipeline Programs	Fosun Pharma	Various Cancer Types	Multiple Phases	Active
Immunomodulation Programs	Fosun Pharma	Autoimmune Disorders	Various Phases	Active
CNS Programs	Fosun Pharma	Neurological Disorders	Various Phases	Active
Metabolic Disease Programs	Fosun Pharma	Diabetes and Metabolic Disorders	Various Phases	Active